An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.


Updates from The Motley Fool

Latest updates on Exact Sciences from Fool.com.  The Fool has written over 100 articles on Exact Sciences.


Stock Performance

View Interactive EXAS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Exact Sciences.
Current Price: $51.56
Prev Close: $51.22
Open: $51.24
Bid: $50.75
Ask: $52.64
Day's Range: $50.30 - $52.02
52wk Range: $13.05 - $63.60
Volume: 2,755,317
Avg Vol 1,639,952
Market Cap: $6B
P/E (ttm): -44.93
EPS (ttm): ($1.14)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Exact Sciences.
CAPS Rating 2 out of 5
 
244 Outperform
46 Underperform
CAPS All Stars
 
45 Outperform
19 Underperform

How do you think Exact Sciences will perform against the market?



You pick for Exact Sciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kevin T. Conroy, CEO

92% Approve

Based on 31 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Exact Sciences.

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers